Skip to main content
SpringerLink
Log in

High prevalence of elevated blood pressure among children with neurofibromatosis type 1

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

Neurofibromatosis type 1 (NF1) is a common neurocutaneous disease characterized by café-au-lait spots, axillary and inguinal freckling, neurofibromas, and optic gliomas. Increased rates of hypertension (HTN) were reported among NF1 patients, however, the prevalence of HTN and pre-HTN in pediatric NF1 patients has not been clarified.

Methods

Blood pressure (BP) measurements, weight, and renal ultrasound were assessed in 224 NF1 pediatric patients followed in a specialized NF1 clinic.

Results

The cohort’s mean age was 9.1 ± 4.1 years. Overweight and obesity were found in 12.9 and 10.3 % of them, respectively. BP was measured averagely 2.9 times per patient on different occasions. Blood pressure was in the pre-HTN and HTN ranges in 14.9 and 16.9 % of measurements, respectively. BP >95th was detected in 20.5 % at the first measurement. Of 114 children with at least three BP measurements, 18.4 % had two values in the HTN range and 6.14 % had at least three. Overweight was not associated with HTN among children with NF1. Urinary tract ultrasonographic abnormalities were detected in 6.8 % (11/161) of cases.

Conclusions

The prevalence of increased BP in pediatric NF1 is much higher than in the general pediatric population. BP has to be regularly assessed and managed in this high-risk population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. McNiece KL, Poffenbarger TS, Turner JL, Franco KD, Sorof JM, Portman RJ (2007) Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr 150(6):640–644, 644.e641

    Article  PubMed  Google Scholar 

  2. Hansen ML, Gunn PW, Kaelber DC (2007) Underdiagnosis of hypertension in children and adolescents. JAMA 298(8):874–879

    Article  CAS  PubMed  Google Scholar 

  3. Flynn J, Zhang Y, Solar-Yohay S, Shi V (2012) Clinical and demographic characteristics of children with hypertension. Hypertension 60(4):1047–1054

    Article  CAS  PubMed  Google Scholar 

  4. Sorof JM, Lai D, Turner J, Poffenbarger T, Portman RJ (2004) Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics 113(3 Pt 1):475–482

    Article  PubMed  Google Scholar 

  5. Arar MY, Hogg RJ, Arant BS Jr, Seikaly MG (1994) Etiology of sustained hypertension in children in the southwestern United States. Pediatr Nephrol 8(2):186–189

    Article  CAS  PubMed  Google Scholar 

  6. Cabral AJ, Silvestre C, Loureiro H, Almeida HI (2013) Renovascular hypertension in an 8-year-old girl. BMJ Case Rep. doi:10.1136/bcr-2013009-

    PubMed Central  PubMed  Google Scholar 

  7. Han M, Criado E (2005) Renal artery stenosis and aneurysms associated with neurofibromatosis. J Vasc Surg 41(3):539–543

    Article  PubMed  Google Scholar 

  8. Chhadia S, Cohn RA, Vural G, Donaldson JS (2013) Renal Doppler evaluation in the child with hypertension: a reasonable screening discriminator? Pediatr Radiol 43(12):1549–1556

    Article  PubMed  Google Scholar 

  9. Falkner B (2010) Hypertension in children and adolescents: epidemiology and natural history. Pediatr Nephrol 25(7):1219–1224

    Article  PubMed Central  PubMed  Google Scholar 

  10. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114(2 Suppl 4th Report):555–576

    Article  Google Scholar 

  11. Falkner B, Daniels SR (2004) Summary of the fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Hypertension 44(4):387–388

    Article  CAS  PubMed  Google Scholar 

  12. Lo JC, Sinaiko A, Chandra M, Daley MF, Greenspan LC, Parker ED, Kharbanda EO, Margolis KL, Adams K, Prineas R, Magid D, O’Connor PJ (2013) Prehypertension and hypertension in community-based pediatric practice. Pediatrics 131(2):e415–e424

    Article  PubMed Central  PubMed  Google Scholar 

  13. Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, Lalloo F (2010) Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet Part A 152a(2):327–332

    Article  CAS  PubMed  Google Scholar 

  14. Friedman JM (1993) Neurofibromatosis 1. In: Pagon RA, Adam MP, Ardinger HH (eds) GeneReviews(R). University of Washington, Seattle. http://www.ncbi.nlm.nih.gov/books/NBK1109/

  15. Riccardi VM (1992) Type 1 neurofibromatosis and the pediatric patient. Curr Prob Pediatr 22(2):66–106, discussion 107

    CAS  Google Scholar 

  16. Jett K, Friedman JM (2010) Clinical and genetic aspects of neurofibromatosis 1. Genet Med 12(1):1–11

    Article  PubMed  Google Scholar 

  17. Lama G, Graziano L, Calabrese E, Grassia C, Rambaldi PF, Cioce F, Tedesco MA, Di Salvo G, Esposito-Salsano M (2004) Blood pressure and cardiovascular involvement in children with neurofibromatosis type1. Pediatr Nephrol 19(4):413–418

    Article  PubMed  Google Scholar 

  18. Tedesco MA, Di Salvo G, Ratti G, Natale F, Calabrese E, Grassia C, Iacono A, Lama G (2001) Arterial distensibility and ambulatory blood pressure monitoring in young patients with neurofibromatosis type 1. Am J Hypertens 14(6 Pt 1):559–566

    Article  CAS  PubMed  Google Scholar 

  19. Finley JL, Dabbs DJ (1988) Renal vascular smooth muscle proliferation in neurofibromatosis. Hum Pathol 19(1):107–110

    Article  CAS  PubMed  Google Scholar 

  20. Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, Upadhyaya M, Towers R, Gleeson M, Steiger C, Kirby A (2007) Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 44(2):81–88

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Bausch B, Borozdin W, Neumann HP (2006) Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma. N Engl J Med 354(25):2729–2731

    Article  CAS  PubMed  Google Scholar 

  22. Viera AJ, Neutze DM (2010) Diagnosis of secondary hypertension: an age-based approach. Am Fam Physician 82(12):1471–1478

    PubMed  Google Scholar 

  23. DeBella K, Szudek J, Friedman JM (2000) Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics 105(3 Pt 1):608–614

    Article  CAS  PubMed  Google Scholar 

  24. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL (2002) 2000 CDC growth charts for the United States: methods and development. Vital and health statistics Series 11, Data from the national health survey (246):1–190 http://www.cdc.gov/nchs/data/series/sr_11/sr11_246.pdf

  25. Booth C, Preston R, Clark G, Reidy J (2002) Management of renal vascular disease in neurofibromatosis type 1 and the role of percutaneous transluminal angioplasty. Nephrol Dial Transplant 17(7):1235–1240

    Article  PubMed  Google Scholar 

  26. Kaas B, Huisman TA, Tekes A, Bergner A, Blakeley JO, Jordan LC (2013) Spectrum and prevalence of vasculopathy in pediatric neurofibromatosis type 1. J Child Neurol 28(5):561–569

    Article  PubMed Central  PubMed  Google Scholar 

  27. Fossali E, Signorini E, Intermite RC, Casalini E, Lovaria A, Maninetti MM, Rossi LN (2000) Renovascular disease and hypertension in children with neurofibromatosis. Pediatr Nephrol 14(8–9):806–810

    Article  CAS  PubMed  Google Scholar 

  28. Shashaj B, Bedogni G, Graziani MP, Tozzi AE, DiCorpo ML, Morano D, Tacconi L, Veronelli P, Contoli B, Manco M (2014) Origin of cardiovascular risk in overweight preschool children: a cohort study of cardiometabolic risk factors at the onset of obesity. JAMA Pediatr 168(10):917–924

    Article  PubMed  Google Scholar 

  29. Zoller M, Rembeck B, Akesson HO, Angervall L (1995) Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Goteborg. Sweden Acta dermato-venereologica 75(2):136–140

    CAS  PubMed  Google Scholar 

  30. Falkner B, Gidding SS, Portman R, Rosner B (2008) Blood pressure variability and classification of prehypertension and hypertension in adolescence. Pediatrics 122(2):238–242

    Article  PubMed  Google Scholar 

  31. Wong SN, Sung RYT, Leung LCK (2006) Validation of three oscillometric blood pressure devices against auscultatory mercury sphygmomanometer in children blood pressure monitoring. Blood Press Monit 11:281–291

    Article  PubMed  Google Scholar 

  32. Pavan MV, Saura GE, Korkes HA, Nascimento KM, Madeira Neto ND, Dávila R, Rodrigues CI, Almeida FA (2012) Similarity between blood pressure values assessed by auscultatory method with mercury sphygmomanometer and automated oscillometric digital device. J Bras Nefrol 34(1):43–49

    Article  PubMed  Google Scholar 

  33. Alpert BS (2007) Validation of the Welch Allyn spot vital signs blood pressure device according to the ANSI/AAMI SP10: 2002. Accuracy and cost-efficiency successfully combined. Blood Press Monit 12(5):345–347

    Article  PubMed  Google Scholar 

  34. Mattu GS, Heran BS, Wright JM (2004) Comparison of the automated non-invasive oscillometric blood pressure monitor (BpTRU™) with the auscultatory mercury sphygmomanometer in a paediatric population. Blood Press Monit 9(1):39–45

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Esther Eshkol for English editing and David Ben-Shimol for technical assistance.

Ethical approval

The study was approved by the institutional ethical committee, and parental consent was not required for this retrospective anonymous chart review.

Conflict of interest

The authors declare that they have no conflicts of interest.

Author information

Authors and Affiliations

  1. Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel

    Tom Dubov, Hagit Toledano-Alhadef, Gil Chernin, Shlomi Constantini, Roxana Cleper & Shay Ben-Shachar

  2. The Gilbert Israeli Neurofibromatosis Center, Tel-Aviv Medical Center, Tel-Aviv, Israel

    Tom Dubov, Hagit Toledano-Alhadef, Shlomi Constantini & Shay Ben-Shachar

  3. Nephrology Department, Tel-Aviv Medical Center, Tel-Aviv, Israel

    Gil Chernin

  4. Pediatric Nephrology Service, Tel-Aviv Medical Center, Tel-Aviv, Israel

    Roxana Cleper

Authors
  1. Tom Dubov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hagit Toledano-Alhadef
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gil Chernin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shlomi Constantini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Roxana Cleper
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shay Ben-Shachar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shay Ben-Shachar.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dubov, T., Toledano-Alhadef, H., Chernin, G. et al. High prevalence of elevated blood pressure among children with neurofibromatosis type 1. Pediatr Nephrol 31, 131–136 (2016). https://doi.org/10.1007/s00467-015-3191-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-015-3191-6

Keywords

Search

Navigation